Financial Snapshot

Revenue
$384.9M
TTM
Gross Margin
64.53%
TTM
Net Earnings
-$836.0K
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
188.41%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$304.7M
Q3 2024
Cash
Q3 2024
P/E
-1.487K
Nov 29, 2024 EST
Free Cash Flow
$11.25M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Revenue $354.0M $313.8M $298.8M $253.2M $276.2M $262.8M $189.7M $180.4M
YoY Change 12.82% 5.0% 18.01% -8.32% 5.09% 38.55% 5.17%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Selling, General & Admin $209.0M $157.4M $169.8M $141.1M $143.0M $140.6M $101.2M $91.55M
YoY Change 32.73% -7.26% 20.29% -1.31% 1.73% 38.89% 10.56%
% of Gross Profit 91.19% 77.74% 85.96% 84.12% 78.14% 81.26% 78.68% 77.0%
Research & Development $28.71M $38.88M $35.55M $24.21M $22.96M $23.10M $19.46M $13.45M
YoY Change -26.16% 9.38% 46.84% 5.43% -0.6% 18.69% 44.73%
% of Gross Profit 12.53% 19.2% 18.0% 14.43% 12.55% 13.35% 15.13% 11.31%
Depreciation & Amortization $23.08M $22.44M $23.98M $20.71M $18.32M $18.10M $9.745M $8.384M
YoY Change 2.83% -6.4% 15.76% 13.08% 1.23% 85.68% 16.23%
% of Gross Profit 10.07% 11.08% 12.14% 12.34% 10.01% 10.46% 7.58% 7.05%
Operating Expenses $237.7M $196.3M $205.3M $165.3M $166.0M $163.7M $120.7M $105.0M
YoY Change 21.07% -4.38% 24.18% -0.38% 1.4% 35.63% 14.93%
Operating Profit $5.742M $6.201M $8.117M $2.441M $17.04M $9.312M $7.970M $21.82M
YoY Change -7.4% -23.6% 232.53% -85.68% 83.01% 16.84% -63.47%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Interest Expense $25.30M $18.22M $16.90M $16.70M $14.90M $15.80M $4.900M $3.000M
YoY Change 38.83% 7.83% 1.2% 12.08% -5.7% 222.45% 63.33%
% of Operating Profit 440.61% 293.89% 208.21% 684.15% 87.43% 169.67% 61.48% 13.75%
Other Income/Expense, Net -$3.106M -$3.108M -$6.136M -$3.134M -$1.250M -$141.0K $260.0K -$437.0K
YoY Change -0.06% -49.35% 95.79% 150.72% 786.52% -154.23% -159.5%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Pretax Income -$21.59M -$14.98M -$14.83M -$17.17M $1.644M $4.560M $5.086M $17.87M
YoY Change 44.06% 1.06% -13.67% -1144.65% -63.95% -10.34% -71.55%
Income Tax $9.104M $4.208M $7.000K -$492.0K -$76.00K -$3.551M -$143.0K $7.634M
% Of Pretax Income -4.62% -77.87% -2.81% 42.71%
Net Earnings -$30.69M -$19.19M -$14.83M -$16.68M $1.720M -$2.840M $3.704M $10.78M
YoY Change 59.91% 29.38% -11.08% -1069.88% -160.56% -176.67% -65.63%
Net Earnings / Revenue -8.67% -6.12% -4.96% -6.59% 0.62% -1.08% 1.95% 5.98%
Basic Earnings Per Share -$0.75 -$0.48 -$0.38 -$0.44 $0.05 -$0.08 $0.11 $0.33
Diluted Earnings Per Share -$0.75 -$0.48 -$0.38 -$0.44 $0.05 -$0.08 $0.11 $0.32

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Cash & Short-Term Investments $58.94M $39.35M $55.01M $61.41M $33.77M $41.49M $39.98M $56.64M
YoY Change 49.78% -28.47% -10.42% 81.88% -18.61% 3.78% -29.42%
Cash & Equivalents $58.94M $39.35M $55.01M $61.41M $33.77M $41.49M $39.98M $56.64M
Short-Term Investments
Other Short-Term Assets $65.61M $63.92M $57.61M $51.39M $44.69M $40.77M $41.18M $34.20M
YoY Change 2.65% 10.95% 12.11% 14.98% 9.62% -0.99% 20.4%
Inventory $81.98M $74.48M $76.97M $73.04M $53.07M $45.48M $46.68M $26.29M
Prepaid Expenses
Receivables $71.80M $61.82M $53.02M $45.96M $52.94M $47.11M $47.53M $27.77M
Other Receivables $2.342M $7.764M $5.086M $2.788M $2.921M $4.324M $3.916M $2.327M
Total Short-Term Assets $280.7M $247.3M $247.7M $234.6M $187.4M $179.2M $179.3M $147.2M
YoY Change 13.48% -0.15% 5.59% 25.19% 4.59% -0.06% 21.77%
Property, Plant & Equipment $82.18M $80.53M $83.24M $51.65M $54.14M $31.03M $33.58M $18.50M
YoY Change 2.05% -3.25% 61.16% -4.61% 74.5% -7.6% 81.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.981M $8.653M $10.62M $16.05M $19.69M $12.03M $9.099M $5.470M
YoY Change 15.35% -18.55% -33.8% -18.49% 63.63% 32.25% 66.34%
Total Long-Term Assets $511.7M $515.5M $545.4M $554.8M $418.3M $391.9M $410.4M $168.9M
YoY Change -0.72% -5.48% -1.71% 32.65% 6.72% -4.51% 142.98%
Total Assets $792.4M $762.8M $793.1M $789.4M $605.7M $571.1M $589.7M $316.1M
YoY Change
Accounts Payable $13.32M $12.00M $10.40M $9.623M $9.796M $7.547M $9.767M $5.744M
YoY Change 10.95% 15.48% 8.02% -1.77% 29.8% -22.73% 70.04%
Accrued Expenses $36.28M $31.60M $27.69M $27.05M $28.84M $21.23M $25.43M $18.68M
YoY Change 14.8% 14.14% 2.37% -6.23% 35.83% -16.5% 36.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.033M $2.121M $2.158M $1.809M $1.761M $1.889M $1.296M $4.562M
YoY Change -4.15% -1.71% 19.29% 2.73% -6.78% 45.76% -71.59%
Total Short-Term Liabilities $57.86M $49.68M $44.95M $60.47M $45.20M $34.52M $42.94M $30.10M
YoY Change 16.48% 10.5% -25.66% 33.79% 30.91% -19.6% 42.65%
Long-Term Debt $308.9M $310.1M $311.9M $295.8M $220.0M $221.7M $225.1M $67.01M
YoY Change -0.39% -0.55% 5.44% 34.45% -0.75% -1.53% 235.9%
Other Long-Term Liabilities $122.0M $94.15M $106.7M $69.74M $28.93M $12.58M $14.17M $10.04M
YoY Change 29.54% -11.76% 53.0% 141.05% 130.07% -11.26% 41.11%
Total Long-Term Liabilities $430.9M $404.3M $418.6M $365.5M $248.9M $234.2M $239.3M $77.06M
YoY Change 6.58% -3.41% 14.52% 46.84% 6.27% -2.1% 210.51%
Total Liabilities $510.6M $478.5M $492.3M $460.7M $320.0M $296.0M $312.6M $107.2M
YoY Change 6.72% -2.81% 6.87% 43.98% 8.09% -5.31% 191.75%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Basic Shares Outstanding 40.74M shares 40.03M shares 38.98M 37.86M 37.12M 36.41M 33.01M 31.86M
Diluted Shares Outstanding 40.74M shares 40.03M shares 38.98M 37.86M 37.86M 36.41M 34.16M 32.82M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $1.2429 Billion

About ARTIVION, INC.

Artivion, Inc. engages in the research and development of solutions which address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. The company is headquartered in Kennesaw, Georgia and currently employs 1,500 full-time employees. The firm's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. The company has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. The company also sells or distributes PhotoFix bovine surgical patches.

Industry: Surgical & Medical Instruments & Apparatus Peers: ABBOTT LABORATORIES Senseonics Holdings, Inc. Axogen, Inc. Cardiovascular Systems Inc Cue Health Inc. Outset Medical, Inc. Inogen Inc MESA LABORATORIES INC /CO/ ViewRay, Inc. SI-BONE, Inc.